Difficulty: Medium
Average Score: 71%
Practice
All of the following factors may increase the risk of nephrotoxicity from gentamicin therapy except
Correct answer
D
Rationale
In the context of gentamicin therapy and the risk of nephrotoxicity, understanding the factors that contribute to this adverse effect is crucial for healthcare professionals.
Option A, age over 70 years, is a risk factor for nephrotoxicity because renal function tends to decline with age, making elderly individuals more vulnerable to drug-induced kidney damage. Prolonged courses of gentamicin therapy (Option B) increase the cumulative exposure to the drug, heightening the risk of nephrotoxicity. Concurrent amphotericin B therapy (Option C) is also a risk factor as both drugs have nephrotoxic potential, and their combined use can synergistically increase kidney damage.
The correct answer, Option D, states that trough gentamicin levels below 2 mg/ml do not increase the risk of nephrotoxicity. This is because higher drug concentrations are more likely to cause kidney damage. Monitoring and maintaining appropriate drug levels within the therapeutic range are essential to minimize toxicity while ensuring efficacy.
In an educational context, it is important to emphasize the significance of individualizing drug therapy based on patient characteristics and closely monitoring for adverse effects. Understanding the risk factors associated with nephrotoxicity from gentamicin helps healthcare providers make informed decisions to optimize patient outcomes and prevent harm.
Option A, age over 70 years, is a risk factor for nephrotoxicity because renal function tends to decline with age, making elderly individuals more vulnerable to drug-induced kidney damage. Prolonged courses of gentamicin therapy (Option B) increase the cumulative exposure to the drug, heightening the risk of nephrotoxicity. Concurrent amphotericin B therapy (Option C) is also a risk factor as both drugs have nephrotoxic potential, and their combined use can synergistically increase kidney damage.
The correct answer, Option D, states that trough gentamicin levels below 2 mg/ml do not increase the risk of nephrotoxicity. This is because higher drug concentrations are more likely to cause kidney damage. Monitoring and maintaining appropriate drug levels within the therapeutic range are essential to minimize toxicity while ensuring efficacy.
In an educational context, it is important to emphasize the significance of individualizing drug therapy based on patient characteristics and closely monitoring for adverse effects. Understanding the risk factors associated with nephrotoxicity from gentamicin helps healthcare providers make informed decisions to optimize patient outcomes and prevent harm.